N,N-Dimethyl-1-dodecanamine structure
|
Common Name | N,N-Dimethyl-1-dodecanamine | ||
|---|---|---|---|---|
| CAS Number | 112-18-5 | Molecular Weight | 213.403 | |
| Density | 0.8±0.1 g/cm3 | Boiling Point | 265.2±3.0 °C at 760 mmHg | |
| Molecular Formula | C14H31N | Melting Point | −20 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 106.9±4.7 °C | |
| Symbol |
GHS05, GHS07, GHS09 |
Signal Word | Danger | |
| Name | N,N-Dimethyldodecylamine |
|---|---|
| Synonym | More Synonyms |
| Density | 0.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 265.2±3.0 °C at 760 mmHg |
| Melting Point | −20 °C(lit.) |
| Molecular Formula | C14H31N |
| Molecular Weight | 213.403 |
| Flash Point | 106.9±4.7 °C |
| Exact Mass | 213.245651 |
| PSA | 3.24000 |
| LogP | 5.91 |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.442 |
| Storage condition | -20°C |
| Water Solubility | Negligible |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS05, GHS07, GHS09 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H302-H314-H410 |
| Precautionary Statements | P273-P280-P303 + P361 + P353-P304 + P340 + P310-P305 + P351 + P338-P391 |
| Personal Protective Equipment | Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | C:Corrosive |
| Risk Phrases | R22;R34 |
| Safety Phrases | S26-S36/37/39-S45-S60-S61 |
| RIDADR | UN 2735 8/PG 2 |
| WGK Germany | 2 |
| RTECS | JR6600000 |
| Packaging Group | III |
| Hazard Class | 8 |
| HS Code | 2921199090 |
| Precursor 10 | |
|---|---|
| DownStream 8 | |
| HS Code | 2921199090 |
|---|---|
| Summary | 2921199090 other acyclic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
|
Signal Transduction Reaction Monitoring Deciphers Site-Specific PI3K-mTOR/MAPK Pathway Dynamics in Oncogene-Induced Senescence.
J. Proteome Res. 14 , 2906-14, (2015) We report a straightforward strategy to comprehensively monitor signal transduction pathway dynamics in mammalian systems. Combining targeted quantitative proteomics with highly selective phosphopepti... |
|
|
Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging.
Small 10(24) , 5137-50, (2014) The blood-brain barrier (BBB) remains a formidable obstacle in medicine, preventing efficient penetration of chemotherapeutic and diagnostic agents to malignant gliomas. Here, a transactivator of tran... |
|
|
RGS19 converts iron deprivation stress into a growth-inhibitory signal
Biochem. Biophys. Res. Commun. 464 , 168-75, (2015) Iron chelation is a promising therapeutic strategy for cancer that works, in part, by inducing overexpression of N-myc downstream-regulated gene 1 protein (NDRG1), a known growth inhibitor and metasta... |
| dimethyl dodecyl amine |
| N-dodecyl-N,N-dimethylamine |
| lauryl dimethyl amine |
| ipl |
| EINECS 203-943-8 |
| Adma12 |
| 1-(Dimethylamino)dodecane,DDA |
| N,N-Dimethyllaurylamine |
| 1-(Dimethylamino)dodecane |
| N,N-Dimethyl-1-dodecanamine |
| N,N-Dimethyldodecan-1-amine |
| dodecyl-dimethylamine |
| 12N1&1 |
| rc5629 |
| N,N-dimethyl-laurylamine |
| 1-Dodecanamine, N,N-dimethyl- |
| ADAM-2 |
| EmpigenABE |
| n-dodecyl dimethylamine |
| Adma 2 |
| barlene125 |
| DMA12 |
| MFCD00008970 |
| N,N-dimethyl-n-dodecylamine |